Genetic Engineering Platform

Based on BGI's high-throughput sequencing technology, HGI established a new method to explore in vitro hematopoietic stem cell modification and optimization of culture conditions. This new method enables HGI to analyze the molecular mechanism of hematopoietic stem cell maintenance and differentiation, and to optimize cell production and preparation processes.

info@hemogen.cn